• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

iCad

iCad, Microsoft collab on mammography access

April 29, 2025 By Sean Whooley

iCad (Nasdaq:ICAD) announced today that it entered into a collaboration with Microsoft to advance AI-powered mammography solutions. Nashua, New Hampshire-based iCad — set to be acquired by RadNet — says the collaboration includes a set of AI-powered mammography solutions in its ProFound Breast Health Suite. These will go on Microsoft’s Precision Imaging Network. The deal […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Diagnostics, Digital Health, Health Technology, Imaging, Machine Learning (ML), Mammography, Software / IT, Women's Health Tagged With: iCad, Microsoft

RadNet to acquire iCad

April 16, 2025 By Sean Whooley

RadNet (Nasdaq:RDNT) announced an agreement to acquire iCad (Nasdaq:ICAD) in an all-stock transaction for approximately $103 million. Under the agreement, iCad stockholders receive 0.0677 shares of RadNet common stock for each iCad share held at closing. Based on RadNet’s closing price on Monday, April 14, 2025, this brings the transaction’s value to approximately $103 million. […]

Filed Under: Artificial Intelligence (AI), Business/Financial News, Diagnostics, Digital Health, Health Technology, Imaging, Machine Learning (ML), Mammography, Mergers & Acquisitions, Software / IT, Women's Health Tagged With: iCad, iCad Inc., RadNet

FDA clears AI-powered breast cancer detection tech from iCad

November 12, 2024 By Sean Whooley

iCad (Nasdaq:ICAD) announced today that the FDA cleared its ProFound Detection version 4.0 for digital breast tomosynthesis (DBT). Nashua, New Hampshire-based iCad trained its next-generation AI solution using deep learning convolutional neural networks (CNN). It offers advancements in cancer detection and specificity, improving the identification of hard-to-find and aggressive cancers. The technology also reduces false […]

Filed Under: Artificial Intelligence (AI), Diagnostics, Health Technology, Imaging, Machine Learning (ML), Mammography, Software / IT Tagged With: FDA, iCad, iCad Inc.

iCad AI tech accurately predicts breast cancer risk, provides heart disease insights

November 27, 2023 By Sean Whooley

iCad (Nasdaq:ICAD) today announced plans to present new studies validating its AI-powered ProFound Breast Health Suite. ProFound helps to uncover hidden heart or vascular disease and predict a woman’s risk for developing breast cancer in the next 1-2 years. The platform can screen a single mammogram for two of the top causes of death for […]

Filed Under: Cardiovascular, Clinical Trials, Diagnostics, Digital Health, Health Technology, Imaging, Mammography, Software / IT, Women's Health Tagged With: iCad, iCad Inc.

iCad sells Xoft brachytherapy business to Elekta

October 23, 2023 By Danielle Kirsh

iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million. Elekta is taking over the business, effective immediately, and will make final payments to iCad no later than November 6, 2023. As part of the deal, Elekta will assume all liabilities, and employees will transfer with the business. The […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well, Oncology Tagged With: Elekta, iCad, Xoft

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy